Skip to main content
BrainCited

Green Tea Extract (EGCG) pour Oxidative Stress & Neuroinflammation

C Preuves Preuves limitées issues de petites études, mais certains signaux positifs existent.

Research suggests EGCG inhibits beta-amyloid aggregation and provides antioxidant neuroprotection. Strong epidemiological data links regular green tea consumption to reduced cognitive decline risk.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dgreen\u002Dtea\u002Dextract\u0026condition\u003Doxidative\u002Dneuroinflammation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

En conclusion

Research suggests EGCG inhibits beta-amyloid aggregation and provides antioxidant neuroprotection. Strong epidemiological data links regular green tea consumption to reduced cognitive decline risk.

Key Study Findings

Review
Dietary Antioxidants, Polyphenols, and Vascular Health: Insights From Ultrasound Measurement of Carotid Intima-Media Thickness and …
Dose: None vs: None Outcome: None Effet: None None

Population: older adults and individuals with neurodegenerative disorders

Review
Herbal Medicines in Autism Spectrum Disorder: Therapeutic Potential, Plant Components, and Dosage Guidelines.
Dose: None vs: None Outcome: ASD symptom management Effet: None None

Population: Children with autism spectrum disorder

Review
Polyphenols and Alzheimer's Disease: A Review on Molecular and Therapeutic Insights With In Silico Support.
Dose: None vs: None Outcome: Neuroprotection in Alzheimer's disease Effet: None None

Population: Alzheimer's disease (review with in silico)

Review
Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection.
Dose: None vs: None Outcome: None Effet: None None

Population: None

Other 5 weeks
Mitigating Age-Related Cognitive Decline and Oxidative Status in Rats Treated with Catechin and Polyphenon-60.
Dose: None vs: None Outcome: Cognitive function Effet: None None

Population: Rat model

Review
Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic …
Dose: Various phytochemicals vs: None Outcome: Neuroprotection in aging and neurodegeneration Effet: None None

Population: Aging brain and NDD models (review)

Key Statistics

10

Études

800

Participants

Positive

C

Note

Referenced Papers

European journal of … 2020 91 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
250-500 mg/day EGCG
viatea:
3-5 cups/day

Limite supérieure : 800 mg/day EGCG from supplements (hepatotoxicity risk above)

Posologies étudiées dans la recherche

Posologie Durée Effet N
None -- Positive --
None -- Positive --
None -- Positive --
None -- Mixed --
None 5 weeks Positive --
Various phytochemicals -- Positive --
None -- Positive --
None 8 weeks Positive --

Moment optimal de prise : Between meals; avoid on empty stomach

Safety & Side Effects

Effets indésirables signalés

  • Liver toxicity at high doses (>800 mg EGCG/day)
  • Insomnia (caffeine content)
  • Gastrointestinal discomfort
  • Iron absorption reduction

Interactions connues

  • Iron supplements (tannins reduce absorption)
  • Nadolol (reduces blood levels)
  • Blood thinners (mild antiplatelet effect)
  • MAO inhibitors (caffeine interaction)

Apport maximal tolérable : 800 mg/day EGCG from supplements (hepatotoxicity risk above)

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Green Tea Extract (EGCG) help with Oxidative Stress & Neuroinflammation?
Based on 10 studies with 800 participants, there is limited but promising evidence that Green Tea Extract (EGCG) may support Oxidative Stress & Neuroinflammation management. Our evidence grade is C (Some Evidence).
How much Green Tea Extract (EGCG) should I take for Oxidative Stress & Neuroinflammation?
Studies have used various dosages. A commonly studied range is 250-500 mg/day EGCG. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Green Tea Extract (EGCG)?
Reported side effects may include Liver toxicity at high doses (>800 mg EGCG/day), Insomnia (caffeine content), Gastrointestinal discomfort, Iron absorption reduction. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Green Tea Extract (EGCG) and Oxidative Stress & Neuroinflammation?
We rate the evidence as Grade C (Some Evidence). This rating is based on 10 peer-reviewed studies with 800 total participants. The overall direction of effect is positive.

Autres ingrédients pour Oxidative Stress & Neuroinflammation

References

  1. [1] Lei Wang et al.. Phytother Res. 2026. Dietary Antioxidants, Polyphenols, and Vascular Health: Insights From Ultrasound Measurement of Carotid Intima-Media Thickness and Their Association With Cognitive Function … doi:10.1002/ptr.70198 PubMed
  2. [2] Rarchita Sharma et al.. Nutr Neurosci. 2025. Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection. doi:10.1080/1028415X.2025.2469170 PubMed
  3. [3] Guifei Chen et al.. Food Sci Nutr. 2025. Polyphenols and Alzheimer's Disease: A Review on Molecular and Therapeutic Insights With In Silico Support. doi:10.1002/fsn3.70496 PubMed
  4. [4] Nasser M Aldekhail et al.. Altern Ther Health Med. 2025. Herbal Medicines in Autism Spectrum Disorder: Therapeutic Potential, Plant Components, and Dosage Guidelines. PubMed
  5. [5] Silvia Tejada et al.. Nutrients. 2024. Mitigating Age-Related Cognitive Decline and Oxidative Status in Rats Treated with Catechin and Polyphenon-60. doi:10.3390/nu16030368 PubMed
  6. [6] Hamid Mostafavi Abdolmaleky et al.. Nutrients. 2023. Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic Strategies Using Phytochemicals. doi:10.3390/nu15153456 PubMed
  7. [7] Yumin Wang et al.. Front Pharmacol. 2022. Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson's disease. doi:10.3389/fphar.2022.977521 PubMed
  8. [8] Belén Mollá et al.. Mol Neurobiol. 2021. Modulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model. doi:10.1007/s12035-021-02285-1 PubMed
  9. [9] Zhipeng Kan et al.. Mol Nutr Food Res. 2021. Green Tea Suppresses Amyloid β Levels and Alleviates Cognitive Impairment by Inhibiting APP Cleavage and Preventing Neurotoxicity in 5XFAD Mice. doi:10.1002/mnfr.202100626 PubMed
  10. [10] Danica Michaličková et al.. Eur J Pharmacol. 2020. Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis. doi:10.1016/j.ejphar.2020.172973 PubMed
  11. [11] Madhuri Venigalla et al.. Neurochem Int. 2016. Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease. doi:10.1016/j.neuint.2015.10.011 PubMed
  12. [12] Marcos H Okuda et al.. J Nutr Biochem. 2014. Green tea extract improves high fat diet-induced hypothalamic inflammation, without affecting the serotoninergic system. doi:10.1016/j.jnutbio.2014.05.012 PubMed
  13. [13] Kuo-Jen Wu et al.. Evid Based Complement Alternat Med. 2012. Green Tea Extract Ameliorates Learning and Memory Deficits in Ischemic Rats via Its Active Component Polyphenol Epigallocatechin-3-gallate by Modulation of … doi:10.1155/2012/163106 PubMed
  14. [14] Barkha P Patel et al.. Clin Nutr. 2009. Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis. doi:10.1016/j.clnu.2009.06.002 PubMed

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.